Benjamin Mark Schleiff

Researcher

University of Arkansas for Medical Sciences

unknown

3 h-index 3 pubs 26 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Benjamin Mark Schleiff's research investigates the bioactivation and detoxification pathways of diphenylamine nonsteroidal anti-inflammatory drugs (NSAIDs). His work has identified opposing roles for CYP2C9 and CYP3A4 enzymes in these processes. Schleiff has published three papers, accumulating 26 citations and an h-index of 3. His collaborations include researchers at the University of Arkansas for Medical Sciences, such as Grover Miller and Gunnar Boysen, with whom he has co-authored multiple publications. His recent activity indicates ongoing engagement in this area of study.

Metrics

  • h-index: 3
  • Publications: 3
  • Citations: 26

Selected Publications

  • CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics